Abstract

Objective: High thyroid hormone levels have been declared to increase the risk of venous thromboembolism while low levels increasing the risk of bleeding. However, the relations between congenital hypothyroidism (CH) and intraventricular hemorrhage (IVH), especially in the preterm infants, is unknown. In our study, we aimed to investigate the relation between severe intracranial hemorrhage and CH in the very low birth weight (VLBW) infants.

Material and Methods: Data of the VLBW infants admitted to the neonatal intensive care unit were retrospectively recorded between January 2013 and December 2016. Gestational age (GA), birth weight (BW), gender, 1st and 5th minute Apgar score, antenatal steroid administration, maternal thyroid disease, cranial ultrasonography findings, thyroid stimulating hormone (TSH) and free thyroxine (fT4) levels were obtained from the hospital records. Demographic characteristics and IVH were compared between the groups with and without CH.

Results:CH was detected in 26 (4.5 %) of 581 VLBW infants. Gestational age (27.3 ± 1.04 weeks) and BW (978 ± 197 g) were lower in the infants with CH than without CH (GA 28.1 ± 1.2 weeks, BW 1073 ± 226 g) (p<0.001 p=0.037, respectively). There was no significant difference in terms of severe IVH between the groups with CH (7.7 %) and without CH (6.5 %) (p=0.95). In the severe IVH group, the level of sT4 was found to be significantly lower (p=0.018). Results for TSH were similar between the groups with and without severe IVH (p=0.215).

Conclusion: We suggested that CH did not increase the risk of severe IVH in VLBW preterm infants. However, lower sT4 levels in severe IVH group, which was attributed to hypothalamic unresponsiveness to the critical disease and brain damage.

Keywords: Very low birth weight, Congenital hypothyroidism, Cerebral intraventricular hemorrhage, Thyroid function test

References

  1. Belcari F, Placidi G, Guzzetta A, Tonacchera M, Ciampi M, Bartoli A, et al. Thyroid-stimulating hormone levels in the first days of life and perinatal factors associated with sub-optimal neuromotor outcome in preterm infants. J Endocrinol Invest 2011;34:e308-13.
  2. Lee JH, Kim SW, Jeon GW, Sin JB. Thyroid dysfunction in very low birth weight preterm infants. Korean J Pediatr 2015;58:224-9.
  3. Heidari Z, Feizi A, Hashemipour M, Kelishadi R, Amini M. Growth development in children with congenital hypothyroidism: the effect of screening and treatment variables-a comprehensive longitudinal study. Endocrine 2016;54:448-59.
  4. Baysal BT, Baysal B, Genel F, Erdur B, Ozbek E, Demir K, et al. Neurodevelopmental Outcome of Children with Congenital Hypothyroidism Diagnosed in a National Screening Program in Turkey. Indian Pediatr 2017;54:381-4.
  5. Osborn DA, Hunt RW. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2007;(1):CD005948.
  6. LaFranchi S. Thyroid function in the preterm infant. Thyroid 1999;9:71-8.
  7. Hashemipour M, Hovsepian S, Ansari A, Keikha M, Khalighinejad P, Niknam N. Screening of congenital hypothyroidism in preterm, low birth weight and very low birth weight neonates: A systematic review. PediatrNeonatol 2018;59:3-14.
  8. Vigone MC, Caiulo S, DiFrenna M, Ghirardello S, Corbetta C, Mosca F, et al. Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism. J Pediatr 2014;164:1296-302.
  9. Dhital R, Poudel DR, Tachamo N, Gyawali B, Basnet S, Shrestha P, et al. Ischemic Stroke and Impact of Thyroid Profile at Presentation: A Systematic Review and Meta-analysis of Observational Studies. J Stroke Cerebrovasc Dis 2017;26:2926-34.
  10. Akirov A, Shochat T, Shechvitz A, Shimon I, Diker-Cohen T, Robenshtok E. Pre-admission TSH levels predict long-term mortality in adults treated for hypothyroidism. Endocrine 2017;58:481-7.
  11. Weng CH, Chen YH, Lin CH, Luo X, Lin TH. Thyroid disorders and breast cancer risk in Asian population: a nationwide population-based case-control study in Taiwan. BMJ Open 2018;8:e020194.
  12. Suvarna JC, Fande CN. Serum thyroid hormone profile in critically Ill children. Indian J Pediatr 2009;76:1217-21.
  13. Elbers LPB, Fliers E, Cannegieter SC. The influence of thyroid function on the coagulation system and its clinical consequences. J ThrombHaemost 2018;16:634-645.
  14. Tan AP, Svrckova P, Cowan F, Chong WK, Mankad K. Intracranial hemorrhage in neonates: A review of etiologies, patterns and predicted clinical outcomes. Eur J Paediatr Neurol 2018;22:690-717.
  15. Guy VV, Johnny D. Pediatric endocrinology. In: Sperling MA, editor. Disorders of the thyroid in the newborn and infant. 4th ed. Philadelphia (PA): Saunders P, 2014:186-208.
  16. American Academy of Pediatrics, Rose SR; Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown RS; Public Health Committee, Lawson Wilkins Pediatric Endocrine Society, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatric 2006;117:2290-303.
  17. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1.500 gm. J Pediatr 1978;92:529–34.
  18. Ericson JE, Laughon MM. Chorioamnionitis: implications for the neonate. Clin Perinatol 2015;42:155-65.
  19. Männistö T, Mendola P, Reddy U, Laughon SK. Neonatal outcomes and birth weight in pregnancies complicated by maternal thyroid disease. Am J Epidemiol 2013;178:731-40.
  20. Hatipoglu N, Büyükkayhan D, Kurtoglu S. Yenidogan Dönemi Tiroid Hastalıkları. Türkiye Klinikleri J Pediatr Sci 2006;2:63-82.21.
  21. Kantor MJ, Leef KH, Bartoshesky L, Getchell J, Paul DA. Admission thyroid evaluation in very-low-birth-weight infants: association with death and severe intraventricular hemorrhage. Thyroid 2003;13:965-9.
  22. Paul DA, Leef KH, Stefano JL, Bartoshesky L. Thyroid function in very-low-birth-weight infants with intraventricular hemorrhage. Clin Pediatr (Phila) 2000;39:651-6.
  23. Wang F, Pan W, Wang H, Wang S, Pan S, Ge J. Relationship between thyroid function and ICU mortality: a prospective observation study. Crit Care 2012;16:R11.
  24. Suvarna JC, Fande CN. Serum thyroid hormone profile in critically III children. Indian J Pediatr 2009;76:1217-21.
  25. Kurt A, Aygun AD, Sengul I, Sen Y, Citak Kurt AN, Ustundag B. Serum thyroid hormones levels are significantly decreased in septic neonates with poor outcome. J Endocrinol Invest 2011;34:e92-6.
  26. Taşcı Hİ, Erikoğlu M, Toy H, Karaibrahimoğlu A. Course of sepsis in rats with thyroid dysfunction. Turk J Surg 2017;33:175-9.
  27. Dembinski J, Arpe V, Kroll M, Bartmann P, Hieronimi G. Thyroid function in healthy and sick very-low-birth-weight infants thyrotropin and free thyroxine levels until the sixth week of age. Biol Neonate 2001;80:210-4.
  28. Ryckman KK, Spracklen CN, Dagle JM, Murray JC. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone. J Pediatr Endocrinol Metab 2014;27:929-38.
  29. Paul DA,Leef KH, Voss B, Stefano JL, Bartoshesky L. Thyroxine and illness severity in very low-birth-weight infants. Thyroid 2001;11:871-5.
  30. Paul DA, Leef KH, Stefano JL, Bartoshesky L. Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infants. Pediatrics 1998;101:903-7.

How to cite

1.
Çakır U. Evaluation of the Relationship Between Congenital Hypothyroidism and Intraventricular Hemorrhage in the Very Low Birth Weight Infants. Turk J Pediatr Dis [Internet]. 2019 Mar. 26 [cited 2025 Aug. 23];13(2):45-9. Available from: https://turkjpediatrdis.org/article/view/618